. . .

Boston Scientific Corporation (NYSE:BSX) completes a public offering of €900.0 million

 On Tuesday Boston Scientific Corporation (NYSE:BSX) stock rose 2.61% and closed at 41.22. The stock opened the session at $40.22 and touched its highest price point at $41.29. Its recent trading capacity is 7076912 shares versus to its average trading volume of 8474211 shares. The company’s stock’s lowest price point for the session stood at $40.17.BSX traded as low as $ 31.56 in the past 52 weeks, and shares hit its peak level to $43.84.

On Nov. 12, 2019, Boston Scientific Corporation (NYSE:BSX) completed a public offering of €900.0 million aggregate principal amount of 0.625% Senior Notes due 2027 (the Notes).  The Company has applied to list the Notes on the New York Stock Exchange.

In addition, the Company completed its previously declared cash tender offer (the Tender Offer) for up to $1.0 billion aggregate principal amount of certain outstanding senior notes, pursuant to which it accepted $206,429,000, $566,455,000, and $227,117,000 of tendered principal amounts of its 4.125% Senior Notes due 2023, 4.000% Senior Notes due 2028 and 3.850% Senior Notes due 2025, respectively on the early settlement date.

The Company used the net proceeds from the offering to (i) fund the Tender Offer and (ii) pay accrued and unpaid interest, premiums, fees and expenses in connection with the Tender Offer. 

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.

Leave a Reply

Your email address will not be published. Required fields are marked *